Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
1 Green Flag and 1 Red Flag for Novavax
09:30am, Monday, 22'nd Aug 2022
It's been a difficult year for this vaccine maker.
The Rise and Fall of Novavax
08:45am, Sunday, 21'st Aug 2022
The story of Novavax stock over the last few years would make an amazing book.
FDA authorizes emergency use for Novavax Covid-19 vaccine for ages 12 and 17
04:06pm, Saturday, 20'th Aug 2022
Novavax announced on Saturday that its Covid-19 vaccine has been authorized for emergency use by the FDA for adolescents between the ages of 12 and 17.
Novavax COVID-19 vaccine authorized for U.S. teens
07:14pm, Friday, 19'th Aug 2022
The Food and Drug Administration authorized Novavax Inc.'s NVAX, -2.58% COVID-19 vaccine for use in U.S. teenagers on Friday. Novavax's recombinant protein-based vaccine uses different technology than
Covid Stocks Pfizer, Moderna, Novavax Face Their Next Challenge, And It's Worth Billions
12:11pm, Friday, 19'th Aug 2022
The Biden administration is planning to stop paying for Covid vaccines and treatments, a move that could buoy some Covid stocks. The post Covid Stocks Pfizer, Moderna, Novavax Face Their Next Challeng
2 Overrated Growth Stocks I Wouldn't Buy With Free Money
11:00am, Friday, 19'th Aug 2022
Your money is safer in the bank than with these stocks.
Missed BBBY? 10 'Meme Stocks' Are Next Gold Mines, Analysts Say
08:00am, Thursday, 18'th Aug 2022
Chasing best-known favorites may not be the best way to score on Meme stocks, analysts say. Meme stock ETFs can help.
Novavax (NVAX) Seeks FDA Authorization for COVID-19 Booster Dose
01:33pm, Tuesday, 16'th Aug 2022
Novavax (NVAX) seeks label expansion from the FDA for its COVID-19 vaccine as a booster dose in adults. The vaccine is authorized as a primary two-dose regimen in adults.
Why Novavax Stock Eked Out a Gain Today
06:45pm, Monday, 15'th Aug 2022
Investors were cheered by the potential for widened authorizations of the Nuvaxovid vaccine.
Novavax's (NVAX) COVID Vaccine Aids Growth, Overdependence Ails
09:47am, Monday, 15'th Aug 2022
Currently, Novavax (NVAX) has only one marketed product in its portfolio, its protein-based COVID-19 vaccine. However, it is lagging in competition behind mRNA-based vaccines.
Novavax submits FDA application for its COVID-19 booster
08:14am, Monday, 15'th Aug 2022
Novavax Inc. NVAX, +2.80% said Monday that it asked the Food and Drug Administration to authorize its COVID-19 booster for adults. The company's primary series of protein-based shots received FDA auth
2 Tips for Investing in Biotech Stocks With High Growth Potential
09:53am, Sunday, 14'th Aug 2022
Investing in biotech stocks without any drugs on the market can be scary. These suggestions can help you make money in this high-risk sector.
Here's Why Novavax Stock Is Trading Higher
10:53am, Friday, 12'th Aug 2022
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 2.80% to $41.47, though off the session high of $43.06 after the company announced its Novaxovid COVID-19 vaccine has been approved in South
Why Novavax Stock Was Plummeting This Week
07:45am, Friday, 12'th Aug 2022
A hugely disappointing quarter and new bear takes on the company by analysts made for a very bad set of trading days.
Novavax's Revenue Could Fall Even More -- and It's Actually Good News
05:52am, Friday, 12'th Aug 2022
Believe it or not, Novavax's revenue could decline and still cause the stock to soar.
